Main Article Content
Background: The world is currently facing a pandemic due to a new species of the Coronaviridae family called SARS-CoV-2,
discovered in the city of Wuhan in China in December 2019. The WHO has named the resulting disease COVID-19 (Coronavirus
Disease 2019). It has been a global health problem due to its major socio-economic damage. The aim of this study was to
show the prevalence of gastrointestinal and hepatic manifestations in symptomatic children with COVID-19.
Methods: We performed a retrospective study, including 36 symptomatic children infected by SARS-CoV-2 hospitalized at the
mother and child hospital of university hospital of Mohammed VI, Marrakech in Morocco, over a period of 7 months. Clinical
and biological manifestations of the digestive system were evaluated for all patients.
Results: The digestive symptomatology came in second place after the respiratory manifestations. 14 patients (38.89 % of
symptomatic patients) in our study had digestive symptoms on admission: 12 (33.33%) presented with diarrhea, 4 (11.11%) had
abdominal pain and only one child (2.78%) had vomiting. Aspartate aminotransferase (AST) was elevated in one patient, while
alanine transaminase (ALT) was elevated in 6 patients. The prothrombin level was normal in all patients. All patients were discharged
with good general condition without morbidity and mortality.
Conclusion: This study concludes with the high prevalence of digestive manifestations of COVID-19 in symptomatic children.
There were no severe clinical or biological abnormalities in our study. Digestive manifestations during COVID-19 in children
are frequent, which requires the awareness of health professionals
Keywords: COVID-19; digestive manifestations; children.